medical biotechnologyبرتری alisertib همراه TAK-228 در برابر تومور های جامدIn the lab and in the clinic, alisertib with TAK-228 excels against solid tumors Two University of Colorado Cancer Center studies were presented this weekend at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Meeting in Philadelphia, PA showing that using the drug alisertib along with the drug TAK-228 is more effective against triple-negative breast cancer and solid tumors than either …ادامه مطلب